0
2022
Intravenous (iv) Therapy And Vein Access Market

Intravenous (IV) Therapy and Vein Access Market

by Type (Implantable Ports, Intravenous Catheters, Hypodermic Needles, Infusion Pumps, Other), by Medical Application (Volume Expander, Medication Administration, Blood Based Products, Nutrition And Buffer Solution), by End User (Hospitals, Ambulatory Surgical Center, Clinics): Global Opportunity Analysis and Industry Forecast, 2020-2030

✷  Report Code: A02019
Pages: 214
Mar 2022 | 12221 Views
Author(s) : Vikita T , Onkar S
Tables: 152
Charts: 61
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

The global Intravenous Therapy and Vein Access Market size was valued at $22.8 billion in 2020 and is projected to reach $37.5 billion by 2030, growing at a CAGR of 5.1% from 2021 to 2030. Intravenous (IV) therapy is the process of infusion of liquid substances such as electrolytes, medicines, nutrition, and blood-based products directly into the veins as a therapeutic treatment. IV therapy-based treatment is the fastest way of delivering fluids to different parts of the body. This treatment is used for diseases, including heart attack, stroke, and poisoning. The patient in such cases should receive medication at the earliest, and hence IV medication is prescribed. Therefore, some of the drugs prescribed intravenously include chemotherapy drugs antibiotics, antifungal drugs, pain medications, immunoglobulin medication, and drugs for low blood pressure. IV therapy works fast, is easy to monitor, and prevents side effects to the gastrointestinal system. provides quick immune system response and relief from chronic diseases compared to the oral mode of medication. can be easily monitored and comprises an infusion pump that controls the volume of a substance to be administered in the body.

The overall impact COVID-19 remain positive on the IV therapy market. As IV therapy is used in patients suffering from severe COVID-19-associated Acute Respiratory Distress Syndrome (ARDS). For instance,on11 November 2021, the Lancet Respiratory Medicine Journal published the use of intravenous immunoglobulin therapy for the COVID-19 ARDS is an attractive adjuvant for the management of severe COVID-19-associated ARDS because of its ability to simultaneously modulate multiple immune compartments. Thus, increase in number of patients suffering from COVID-19-associated ARDS has increased the demand for IV therapy and vein access product.

 

The Intravenous Therapy and Vein Access Market trends include a rise in the incidence of chronic diseases, growth in road accidents, and a surge in trauma cases. In addition, an increase in healthcare expenditure and healthcare insurance are expected to fuel the Intravenous Therapy and Vein Access Market growth during the forecast period. However, the lack of experienced healthcare professionals restricts the market growth. Conversely, the rise in critical care therapies and the increase in the geriatric population are the key factors that provide Intravenous Therapy and Vein Access Market opportunity.

Furthermore, an increase in the number of approved IV drugs that are used for therapy drives the growth of the market. For instance, according to the journal of New England Journal of Medicine (NEJM), the Artesunate injection was approved by Food and Drug Administration (FDA) in June 2020 for the treatment of malaria.

The Intravenous Therapy and Vein Access Market is segmented on the basis of type, medical application, and region. Depending on the type, the market is classified into implantable ports, IV catheters, hypodermic needles, infusion pumps, and others. According to medical application, the market is categorized into volume expanders, medication administration, blood-based products, and nutrition & buffer solutions. As per end-user, the market is fragmented into hospitals, ambulatory surgical centers, and clinics. Region-wise, the Intravenous Therapy and Vein Access Market analysis is done across North America, Europe, Asia-Pacific, and LAMEA.

By Type Segment Review

Intravenous (IV) Therapy and Vein Access Market
By Type

Your browser does not support the canvas element.

Intravenous Catheters segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

According to type, the Vein Access Industry market is classified into implantable ports, IV catheters, hypodermic needles, infusion pumps, and others. The IV catheters are the fastest growing product segment. The growth of the IV catheter market is fueled by rising in the use of IV catheters during surgical procedures for IV therapies and during the transfer of blood, medicine, and other nutrients to different parts of the body are the key factors driving the growth of the market.

By Medical Application Segment Review

Intravenous (IV) Therapy and Vein Access Market
By Medical Application

Your browser does not support the canvas element.

Medication segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

According to medical applications, the Intravenous Therapy and Vein Access Market market is classified into volume expanders, medication administration, blood-based products, and nutrition & buffer solutions. The medication administration segment held the highest market share, owing to the high usage of IV therapy for transferring medicines for diseases such as diabetes, and cancer.

By End-User Segment Review

Intravenous (IV) Therapy and Vein Access Market
By End User

Your browser does not support the canvas element.

Hospitals segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

As per end-user, the Intravenous Therapy Industry is fragmented into hospitals, ambulatory surgical centers, and clinics. The hospital segment held the highest market share, owing to an increase in the number of surgeries performed compared to ambulatory surgical centers and clinics.

By Region Segment Review

Intravenous (IV) Therapy and Vein Access Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Region-wise, the IV therapy & vein access market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America was the highest Intravenous Therapy and Vein Access Market share in 2020, owing to an increase in the pool of patient population, a rise in prevalence of road accidents, the surge in trauma cases, and an increase in government investments in the development of better healthcare facilities and R&D activities.

The key players operating in the global IV therapy & vein access market include Becton, Dickinson & Company, Braun Melsungen AG, Terumo medical corporation, Teleflex Medical Inc., Medtronic Inc., Angiodynamic, Inc.., Smith& Nephew Plc., Pfizer Inc., Insulet Corporation, and Fresenius SE& CO. KGAA.

The other players (the profiles of these players are not covered in the report) in the value chain include Baxter International Inc., iRadimed Corporation, BioScrip, Inc., Grifols, S.A., JW Life Science Co. Ltd., BRIEF-Sichuan Kelun Pharmaceutical Co. Ltd., CVS Health Corporation, and Vifor Pharma Group.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intravenous (iv) therapy and vein access market analysis from 2020 to 2030 to identify the prevailing intravenous (iv) therapy and vein access market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the intravenous (iv) therapy and vein access market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global intravenous (iv) therapy and vein access market trends, key players, market segments, application areas, and market growth strategies.

Intravenous (IV) Therapy and Vein Access Market Report Highlights

Aspects Details
By Type
  • Implantable Ports
  • Intravenous Catheters
  • Hypodermic Needles
  • Infusion Pumps
  • Other
By Medical Application
  • Nutrition And Buffer Solution
  • Volume Expander
  • Medication Administration
  • Blood Based Products
By End User
  • Hospitals
  • Ambulatory Surgical Center
  • Clinics
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest Of Asia Pacific)
  • LAMEA  (Brazil, South Africa,, Saudi Arabia, Rest of LAMEA)
Key Market Players Medtronic Inc, Teleflex, B. Braun Melunsung, terumo corporation, AngioDynamics, Inc., Fresenius SE and Co. KGaA., Baxter international plc, Pfizer Inc, Cardinal Health Inc., smiths medical
 

Loading Table Of Content...


 
 

According to CXOs, utilization of intravenous (IV) therapy and vein access is expected to witness a significant rise across the globe, owing to  increase in prevalence of chronic disease such as diabetes, cardiovascular disease, autoimmune disorder and rise in geriatric population. IV therapy is the process of infusion of liquid substances such as electrolytes, medicines, nutrition, and blood-based products directly into the veins as a therapeutic treatment.

The key factors that drive the growth of IV therapy and vein access devices market include rise in incidence & prevalence of chronic diseases, growth in road accidents, and surge in trauma cases. In addition, increase in healthcare expenditure and healthcare insurance is expected to fuel the market growth during the forecast  period. However, lack of experienced healthcare professionals restricts the market growth. On the contrary, rise in critical care therapies along with increase in geriatric population are the key factors driving the growth of market.

Furthermore, increase in adoption of IV therapy & vein access products and surge in number of approvals IV  drugs used for therapy are the key factors driving the growth of market. For instance, the Artesunate injection was approved by Food and Drug Administration (FDA) on June 2020 for treatment of malaria.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. North Aerica is the largest regional market for Intravenous (IV) Therapy and Vein Access

A. The top key players operating in the global IV therapy & vein access market include Becton, Dickinson & Company, Braun Melsungen AG, Terumo medical corporation, Teleflex Medical Inc., Medtronic Inc., Angiodynamic, Inc.., Smith& Nephew Plc., Pfizer Inc., Insulet Corporation, and Fresenius SE& CO. KGAA.

A. The Upcoming trends that drive the growth of the IV therapy and vein access devices market include a rise in incidence & prevalence of chronic diseases, growth in road accidents, and surge in trauma cases. In addition, an increase in healthcare expenditure and healthcare insurance is expected to fuel the market growth during the forecast period. However, the lack of experienced healthcare professionals restricts the market growth. Conversely, the rise in critical care therapies and increase in the geriatric population is the key factor driving the growth of market.

A. The Intravenous (IV) Therapy and Vein Access market was valued at $22,808.93 million in 2020

A. The total market value of Intravenous (IV) Therapy and Vein Access Market is $37,537.18 million by 2030

A. No, there is no value chain analysis provided in the Intravenous (IV) Therapy and Vein Access Market Market report

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Intravenous (iv) Therapy And Vein Access Market

Start reading instantly.
This Report and over 19,320+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers